binodenoson

Known as: 2-((Cyclohexylmethylene)hydrazino)adenosine, 2-(cyclohexylmethylidenehydrazino)adenosine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2011
0120042011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Selective adenosine receptor agonists have several advantages for use as stress agents in conjunction with myocardial perfusion… (More)
Is this relevant?
Review
2011
Review
2011
Medicinal chemical approaches have been applied to all four of the adenosine receptor (AR) subtypes (A(1), A(2A), A(2B), and A(3… (More)
Is this relevant?
Review
2009
Review
2009
BACKGROUND The pharmacological stress agents adenosine and dipyridamole are contraindicated in asthma patients because of the… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2008
Review
2008
Myocardial perfusion studies use either physical exercise or pharmacologic vasodilator stress to induce maximum myocardial… (More)
  • figure 1
Is this relevant?
2007
2007
The purpose of this study was to define binodenoson dosing regimens that produce coronary hyperemia comparable to those of… (More)
Is this relevant?
Review
2006
Review
2006
Pharmacologic stress myocardial perfusion imaging is being performed with increasing frequency over exercise stress. Dipyridamole… (More)
Is this relevant?
2005
2005
BACKGROUND Binodenoson, a highly selective agonist of the adenosine A 2A receptor, is being developed as a short-acting coronary… (More)
Is this relevant?
2004
2004
BACKGROUND Dipyridamole and adenosine cause frequent side effects as a result of nonspecific adenosine receptor stimulation… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?